A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 27
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MA
Long Form : macular atrophy
No. Year Title Co-occurring Abbreviation
2020 A Review of Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part II. anti-VEGF, nAMD, RPE
2019 DEVELOPMENT OF MACULAR ATROPHY AFTER PARS PLANA VITRECTOMY FOR MYOPIC TRACTION MACULOPATHY AND MACULAR HOLE RETINAL DETACHMENT IN PATHOLOGIC MYOPIA. PPV
2019 Factors influencing macular atrophy growth rates in neovascular age-related macular degeneration treated with ranibizumab or aflibercept according to an observe-and-plan regimen. ---
2019 Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial. CI, FA, nAMD, OR, VEGF
2019 MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION. CC
2019 Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial Comparing Ranibizumab and Aflibercept (RIVAL Study). AEs, BCVA, CI, nAMD
2019 MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen. ---
2019 Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part I: A Review of Disease Characterization and Morphological Associations. nAMD
2019 OCT-Based Diagnostic Criteria for Different Stages of Myopic Maculopathy. AXL, CT, HM, MDCA, PDCA
10  2019 Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project. aOR, nAMD, VEGF
11  2019 Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration. CAM, nAMD, PRN, SD
12  2019 The Evolution of Fibrosis and Atrophy and Their Relationship with Visual Outcomes in Asian Persons with Neovascular Age-Related Macular Degeneration. nAMD, PCV, SHRM, VA
13  2018 Green emission fluorophores in eyes with atrophic age-related macular degeneration: a colour fundus autofluorescence pilot study. AMD, FAF, GEFC, SD-OCT
14  2018 Long-Term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti-Vascular Endothelial Growth Factor. nAMD, VEGF
15  2018 MACULAR ATROPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Pilot Post Hoc Analysis of Patients With Pigment Epithelial Detachments. ---
16  2018 Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration. AMD, BCVA, CNV, FAs, HR, PRN
17  2018 One-year outcomes of fixed treatment of intravitreal aflibercept for exudative age-related macular degeneration and the factor of visual prognosis. AS, BCVA, CRT, IVA, SCT
18  2018 Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial. AMD, dAMD, NVAMD, ROC, SCT, SDOCT
19  2018 Tomographic Biomarkers Predicting Progression to Fibrosis in Treated Neovascular Age-Related Macular Degeneration: A Multimodal Imaging Study. BCVA, CF, HRM, nAMD, RPE
20  2018 Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial. AMA, BSL, CNV, FA, FAF, NVAMD, SDOCT
21  2017 Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration. CI, nAMD, SDD, VEGF
22  2017 Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial. AMD, ERMA, FAF, FCT, PED, SD-OCT, SHRM, TREX
23  2016 Atrophy of the macula in the context of its wet, age-related degeneration : An inescapable consequence of anti-VEGF therapy? AMD, RPE
24  2016 Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA,and HORIZON (SEVEN-UP Study). AMD, VEGF
25  2016 Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration. AIC, AMD, CNV, IRCs, PVD, RPD, SD-OCT, VEGF
26  2016 PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. ---
27  2014 Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography. BCVA, CFT, IVR, RAP, RPE, SD-OCT